Finance

Lists
1681:HKG
Consun Pharmaceutical Group Ltd
HK$15,68
+1,88%
(+0,29) 1D
16 Okt., 16:08:14 GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 1681...
Open
HK$15,39
High
HK$15,84
Low
HK$15,38
Mkt. cap
13,14 mjd
Avg. vol.
1,48 m
Volume
1,35 m
Dividend
4,97%
Quarterly dividend
HK$0,19
Ex-dividend date
08 Sep. 2026
P/E ratio
9,68
52-wk high
HK$19,49
52-wk low
HK$12,31
EPS
HK$1,62
Shares outstanding
875,19 m
No. of employees
3 k
Open
HK$15,39
High
HK$15,84
Low
HK$15,38
Mkt. cap
13,14 mjd
Avg. vol.
1,48 m
Volume
1,35 m
Dividend
4,97%
Quarterly dividend
HK$0,19
Ex-dividend date
08 Sep. 2026
P/E ratio
9,68
52-wk high
HK$19,49
52-wk low
HK$12,31
EPS
HK$1,62
Shares outstanding
875,19 m
No. of employees
3 k
News stories
From web sources and news partners
About Consun Pharmaceutical Group Ltd
CEO-
Employees2,85 k
Founded1997
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
924,38 m
924,38 m
892,34 m
892,34 m
Cost of goods sold
195,16 m
195,16 m
166,31 m
166,31 m
Cost of revenue
195,16 m
195,16 m
166,31 m
166,31 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
412,59 m
412,59 m
398,41 m
398,41 m
Operating expense
410,59 m
410,59 m
394,20 m
394,20 m
Total operating expenses
605,75 m
605,75 m
560,51 m
560,51 m
Operating income
318,63 m
318,63 m
331,83 m
331,83 m
Other non operating income
-
-
-
-
EBT including unusual items
330,59 m
330,59 m
349,17 m
349,17 m
EBT excluding unusual items
331,38 m
331,38 m
349,76 m
349,76 m
Income tax expense
37,45 m
37,45 m
50,10 m
50,10 m
Effective tax rate
11,33%
11,33%
14,35%
14,35%
Other operating expenses
-1,19 m
-1,19 m
-5,01 m
-5,01 m
Net income
289,88 m
289,88 m
297,65 m
297,65 m
Net profit margin
31,36%
31,36%
33,36%
33,36%
Earnings per share
-
-
-
-
Interest and investment income
21,11 m
21,11 m
20,36 m
20,36 m
Interest expense
-946,00 k
-946,00 k
-1,34 m
-1,34 m
Net interest expenses
20,16 m
20,16 m
19,01 m
19,01 m
Depreciation and amortization charges
-
-
-
-
EBITDA
332,28 m
332,28 m
346,72 m
346,72 m
Gain or loss from assets sale
965,50 k
965,50 k
-
-
AI content may include mistakes. Learn more
Google-programme